You are here
ASURAGEN, INC.
UEI: E8M9NXN4X4Y7
# of Employees: 121
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
AmplideX DeepNet, a new paradigm for deep learning analytical tools in the molecular diagnostic space
Amount: $223,058.00Project SummaryAn extensible analysis platform will be developed to accurately perform the automated genotyping of PCR capillary electrophoresisCEtraces for multiple disease associated short tandem re ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
A single test utilizing a unified multiplex PCR/CE workflow targeting five dominant inherited ataxias
Amount: $181,033.00Summary Our goal is to develop and commercialize a multiplexed assay for dominant hereditary ataxias to rapidly and accurately analyze short tandem repeatSTRlengths leading to a positive impact on DNA ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
Single cell prenatal testing of circulating trophoblasts using a the novel immunomagnetic Micro-Aperture Chip (IMAC) system
Amount: $196,910.00Project Summary The overall goal of this project is to develop a rapid non invasive and sensitive system for pre natal testing for fragile X syndrome FXS Asuragen will combine our unique and well char ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
Novel Strategies for Enhanced Detection of Hemoglobinopathy Carriers
Amount: $231,153.00SummaryThe overall goal of this project is to developvalidateand commercialize the first ever hemoglobinopathies panel kit on Oxford Nanopore TechnologiesNP systemcovering deletionsduplications and mu ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
Novel Strategies for Development of a Multiplexed Test with Expanded Content for Spinal Muscular Atrophy
Amount: $182,393.00SummaryThe overall goal of this project is to develop a cost effective multiplexed diagnostic test for spinal muscular atrophySMAto rapidly and accurately analyze multiple classes of disease causingdi ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
Development of a unified information-rich test for CNBP and DMPK to improve assessment of Myotonic Dystrophy Type 1 and 2
Amount: $224,978.00Project SummaryThe long term goal of the project is to developvalidate and commercialize the first FDA cleared IVD test kit for the rapid and differential diagnosis of Myotonic Dystrophy typeDMand DM ...
SBIRPhase I2018Department of Health and Human Services National Institutes of Health -
Novel strategies for enhanced analysis of repeat disorders
Amount: $224,999.00SummaryThe goal of this project is to establish feasibility for diagnostic sequencing of clinically relevant short tandem repeatSTRDNA markers on therd generation MinION nanoporeNPsequencing platformu ...
SBIRPhase I2018Department of Health and Human Services National Institutes of Health -
Improving rare variant detection in next generation sequencing of liquid biopsies with a molecular barcoding technique that combines a novel primer structure and sophisticated bioinformatics methods
Amount: $224,999.00SummaryOur goal is to improve the sensitivityfidelityand efficiency of next generation sequencingNGSfor rare variant detection from liquid biopsy specimensExisting NGS techniques for liquid biopsy ana ...
SBIRPhase I2018Department of Health and Human Services National Institutes of Health -
Development of a unified Alzheimer s disease test that combines high resolution analysis of TOMM and Apolipoprotein E for improved risk estimates
Amount: $224,984.00Project Summary The long term goal of this project is to develop validate and commercialize a PCR based molecular test for routine Alzheimer s disease AD testing that will provide more comprehensi ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
Development of an information rich assay for C ORF as a test for ALS and FTD
Amount: $1,379,750.00Project Summary The long term goal of this project is to develop validate and commercialize an assay for improved analysis of C orf a gene on chromosome that is linked to frontotemporal dement ...
SBIRPhase II2016Department of Health and Human Services National Institutes of Health
